Featured Research

from universities, journals, and other organizations

Making Old Hearts Young Again

Date:
May 9, 2007
Source:
Griffith University
Summary:
Researchers are unravelling the molecular events associated with aging that reduce the ability of older hearts to withstand disease.

Researchers are unravelling the molecular events associated with aging that reduce the ability of older hearts to withstand disease.

Ischaemic heart disease, characterised by reduced blood flow to the heart, is Australia's and the world's leading cause of death. It is most common in older people and the impact of the disease will continue to rise with an ageing population.

Director of Griffith's Heart Foundation Research Centre Professor John Headrick said older hearts become less resistant to damage during heart attack. "Furthermore, new experimental therapies to reduce damage also appear less effective in older hearts. It is therefore critical that we understand how age alters the heart, and how older hearts respond to disease."

Together with researcher Dr Jason Peart, his team have identified normally protective processes within cardiac cells that become ineffective with age. "When we experimentally target this 'cascade of proteins' it is possible to render an aged heart akin to a young heart in terms of its response to a heart attack. This type of research paves the way for new therapies designed to specifically manage heart disease in our older population," Professor Headrick said.

The research is currently supported by grants from the National Heart Foundation and research fellowships from the National Health and Medical Research Council (NHMRC).


Story Source:

The above story is based on materials provided by Griffith University. Note: Materials may be edited for content and length.


Cite This Page:

Griffith University. "Making Old Hearts Young Again." ScienceDaily. ScienceDaily, 9 May 2007. <www.sciencedaily.com/releases/2007/05/070503094505.htm>.
Griffith University. (2007, May 9). Making Old Hearts Young Again. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/05/070503094505.htm
Griffith University. "Making Old Hearts Young Again." ScienceDaily. www.sciencedaily.com/releases/2007/05/070503094505.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins